Cefotaxime

Form: IV and IM Injection

Strength: 250 mg, 500 mg, 1 g, 2 g

Reference Brands: Claforan(US)

Category: Critical Care

Cefotaxime is a third-generation cephalosporin antibiotic used for the treatment of severe bacterial infections such as pneumonia, sepsis, meningitis, and urinary tract infections. Administered via intravenous (IV) or intramuscular (IM) injection, it is available as a lyophilized powder in 250 mg, 500 mg, 1 g, and 2 g vials. In the US, Cefotaxime was initially marketed as Claforan by Sanofi and is now widely available as a generic from Hikma, Sagent, and others. In the EU, leading suppliers include Fresenius Kabi, Sandoz, and Mylan. Pharma B2B platforms enable efficient sourcing of bulk Cefotaxime for hospitals and critical care centers.